Steris (STE) Liabilities from Discontinued Operations (2023 - 2024)
Steris' (STE) quarterly Liabilities from Discontinued Operations came in at 64012000.0 in Q1 2024, up 26.4% year-on-year from 50642000.0 in Q2 2023, and up 26.4% quarter-over-quarter from 50642000.0 in Q1 2023.
Steris (STE) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends
Steris' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 64012000.0 for Q1 2024.
- On a quarterly basis, Liabilities from Discontinued Operations rose 26.4% year-over-year to 64012000.0 in Q1 2024; TTM through Mar 2024 was 64012000.0, a 26.4% increase from a year earlier, with the FY2024 full-year figure at 64012000.0, up 26.4% from the prior year.
- Liabilities from Discontinued Operations advanced to 64012000.0 in Q1 2024 per STE's latest filing, from 50642000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 64012000.0 in Q1 2024 and bottomed at 50642000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Steris | 21.48 Bn | 21.04 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 64.01 Mn |
| Mar 31, 2024 | 64.01 Mn |
| Mar 31, 2023 | 50.64 Mn |
| Mar 31, 2023 | 50.64 Mn |